Anti-allergic composition containing zwitterionic bicyclic compo

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514212, 514239, 514242, 514222, 514249, 514253, 514254, 514256, 514304, 514305, 514312, 514216, A61K 31435

Patent

active

047820675

ABSTRACT:
Zwitterionic bicyclic compounds are disclosed which are useful as anti-allergic, anti-inflammatory and/or cytoprotective agents and in the treatment of hyperproliferative skin disease. Pharmaceutical compositions and methods of treatment employing such compounds are also disclosed.

REFERENCES:
patent: 4264602 (1981-04-01), Hardtmann
Kappe et al., Monatshefte fur Chemie, 99, pp. 2157-2166 (1968).
Merchant et al., Curr. Sci., 49(1), pp. 20-21, (1980); Chem. Abst. vol. 92-181059u (1980).
Wittman et al., Z. Naturforsch., B: Anorg. Chem., Org. Chem., 33B(12), pp. 1540-1546 (1978); Chem. Abst. vol. 90-121339 (1979).
Bowman et al., "The Synthesis of Some Dialkylamino-2-Quinolones," Journal of the Chemical Society, pp. 1350-1353 (1964).
Suzuki et al., Chemical Pharmaceutical Bulletin, 25 (No. 10) 2602-2607 (1977).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-allergic composition containing zwitterionic bicyclic compo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-allergic composition containing zwitterionic bicyclic compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-allergic composition containing zwitterionic bicyclic compo will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-891030

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.